Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
epidermolysis bullosa
Biotech
Almirall signs yes-nonsense deal with Eloxx for $3M upfront
Almirall is handing over $3 million for Eloxx Pharmaceuticals’ molecule for a pair of rare skin diseases just before the drug enters the clinic.
James Waldron
Mar 13, 2024 10:31am
Abeona's rare disease drug heals wounds, eases pain in phase 3
Nov 3, 2022 12:00pm
Amryt's shares tumble as skin treatment spurned by FDA
Feb 28, 2022 11:49am
Gene therapy heals wounds in patients with painful blistering skin disease
Nov 2, 2016 8:45am